Larisa V. Mochalova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Larisa V. Mochalova has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Lubov V. Radygina
Всероссийский институт научной и технической информации Российской академии наук, ул. Усиевича, 20, Москва, 125315 Россия
6 shared publications - Alexsander A. Shilov
Gamaleya National Research Center for Epidemiology and Microbiology
2 shared publications - Alexsander V. Lyashko
Gamaleya National Research Center for Epidemiology and Microbiology
2 shared publications - Boris I. Timofeev
National Research Center for Epidemiology and Microbiology named after honorary academician N.F. Gamaleya
2 shared publications - Elena B. Timofeeva
Gamaleya National Research Center for Epidemiology and Microbiology
2 shared publications - Elena L. Ryazanova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications
Latest Publications
- Open Access
- 1 January 2024
- Published by Doctrine in Microbiology Independent Research Journal (MIR Journal)
- Vol. 11 (1) , 57-69
Diseases caused by human T-lymphotropic virus type 1 (HTLV-1)
INTRODUCTION: Human T-lymphotropic virus type 1 (HTLV-1) belongs to the Retroviridae family (genus Deltaretrovirus) and is directly involved in carcinogenesis. The HTLV-1 genome is represented by plus-strand RNA, which is transcribed into proviral DNA and then integrated into the genome of the host cell. After integration, HTLV-1 is present in the cells in the form of a provirus. As in the case of the human immunodeficiency virus, the main targets of HTLV-1 are CD4+ T lymphocytes. The virus is transmitted sexually, through blood transfusion, and breastfeeding by biological fluids – sperm, blood, and breast milk. The epidemiology of HTLV-1 remains a mystery: clusters of high endemicity are often located near areas where the virus is virtually absent. AIM: To analyze and discuss the clinical picture, diagnostics, and treatment of diseases caused by HTLV-1. METHODS: A literature search was conducted in the databases PubMed, eLIBRARY.ru, and cyberleninka.ru using the keywords: “HTLV-1” + “diseases”, “HTLV-1” + “diagnosis”, “HTLV-1” + “epidemiology”, “HTLV-1” + “treatment”, “HTLV-1” + “Russia” in English and Russian languages. The primary search was conducted for papers published in 2020–2024. RESULTS: HTLV-1 infection is associated with diseases such as T-cell leukemia/lymphoma and myelopathy/tropical spastic paraparesis. HTLV-1 infection causes pathologies in most organs of the human body. Because diseases associated with HTLV-1 are most often asymptomatic, etiological diagnoses are performed at the stage of pathological development or when screening donor blood for pathogens. CONCLUSION: In this review, we analyzed and discussed the clinical manifestations and course of diseases caused by HTLV-1, their diagnosis, and treatment. The lack of reliable population-based studies on the prevalence of this virus is alarming. In fact, HTLV-1 is diagnosed only in blood donors and pregnant women. Currently, this virus is considered endemic to several territories (Africa, Australia, the Middle East, Japan, etc.) and some indigenous peoples. However, we consider it important to draw the attention of both epidemiologists and clinicians to HTLV-1, given the unprecedented migration flows and international connections in the modern world.
- 1 January 2024
- Published by Doctrine in Microbiology Independent Research Journal (MIR Journal)
- Vol. 11 (1) , 57-69
Open AccessDiseases caused by human T-lymphotropic virus type 1 (HTLV-1)
INTRODUCTION: Human T-lymphotropic virus type 1 (HTLV-1) belongs to the Retroviridae family (genus Deltaretrovirus) and is directly involved in carcinogenesis. The HTLV-1 genome is represented by plus-strand RNA, which is transcribed into proviral DNA and then integrated into the genome of the host cell. After integration, HTLV-1 is present in the cells in the form of a provirus. As in the case of the human immunodeficiency virus, the main targets of HTLV-1 are CD4+ T lymphocytes. The virus is transmitted sexually, through blood transfusion, and breastfeeding by biological fluids – sperm, blood, and breast milk. The epidemiology of HTLV-1 remains a mystery: clusters of high endemicity are often located near areas where the virus is virtually absent. AIM: To analyze and discuss the clinical picture, diagnostics, and treatment of diseases caused by HTLV-1. METHODS: A literature search was conducted in the databases PubMed, eLIBRARY.ru, and cyberleninka.ru using the keywords: “HTLV-1” + “diseases”, “HTLV-1” + “diagnosis”, “HTLV-1” + “epidemiology”, “HTLV-1” + “treatment”, “HTLV-1” + “Russia” in English and Russian languages. The primary search was conducted for papers published in 2020–2024. RESULTS: HTLV-1 infection is associated with diseases such as T-cell leukemia/lymphoma and myelopathy/tropical spastic paraparesis. HTLV-1 infection causes pathologies in most organs of the human body. Because diseases associated with HTLV-1 are most often asymptomatic, etiological diagnoses are performed at the stage of pathological development or when screening donor blood for pathogens. CONCLUSION: In this review, we analyzed and discussed the clinical manifestations and course of diseases caused by HTLV-1, their diagnosis, and treatment. The lack of reliable population-based studies on the prevalence of this virus is alarming. In fact, HTLV-1 is diagnosed only in blood donors and pregnant women. Currently, this virus is considered endemic to several territories (Africa, Australia, the Middle East, Japan, etc.) and some indigenous peoples. However, we consider it important to draw the attention of both epidemiologists and clinicians to HTLV-1, given the unprecedented migration flows and international connections in the modern world.
- Open Access
- 1 January 2024
- Published by Doctrine in Microbiology Independent Research Journal (MIR Journal)
- Vol. 11 (1) , 57-69
Заболевания, ассоциированные с Т-лимфотропным вирусом типа 1 человека (HTLV-1)
ВВЕДЕНИЕ: Т-лимфотропный вирус типа 1 человека (HTLV-1) относится к семейству Retroviridae (род Deltaretrovirus) и напрямую участвует в канцерогенезе. Геном HTLV-1 представлен плюс-цепью РНК, которая транскрибируется в провирусную ДНК, а затем встраивается в геном клетки хозяина. После интеграции HTLV-1 присутствует в клетке в форме провируса. Как и для вируса иммунодефицита человека, основными мишенями HTLV-1 служат CD4 + T-лифоциты. Вирус передается через биологические жидкости организма: сперму, кровь и грудное молоко, – то есть половым путем, при гемотрансфузии и грудном вскармливании. Что касается эпидемиологии HTLV-1, то она до сих пор остается загадкой: кластеры с высокой эндемичностью часто расположены вблизи районов, где вирус практически отсутствует. ЦЕЛЬ: Проанализировать клиническую картину, диагностику и лечение заболеваний, вызванных HTLV-1. МЕТОДЫ: Проведен поиск литературы в базах PubMed, elibrary.ru и cyberleninka.ru по ключевым словам: «HTLV-1»+«diseases», «HTLV-1»+«diagnosis», «HTLV-1»+«epidemiology», «HTLV-1»+«treatment», «HTLV-1»+«Russia»; «HTLV-1»+«болезни», «HTLV-1»+«диагностика», «HTLV-1»+«эпидемиология», «HTLV-1»+«лечение», «HTLV-1»+«Россия». Основной поиск проведен за 2020–2024 гг. РЕЗУЛЬТАТЫ: С HTLV-1 связаны такие заболевания, как Т-клеточный лейкоз/лимфома и миелопатия/тропический спастический парапарез. При HTLV-1-инфекции регистрируют патологии большинства систем органов. В связи с тем, что ассоциированные с HTLV-1 заболевания чаще всего протекают бессимптомно, этиологическую диагностику проводят уже на стадии развития патологии или при скрининге крови доноров на патогены. ЗАКЛЮЧЕНИЕ: В обзоре рассмотрены вопросы клинических проявлений и течения заболеваний, вызванных HTLV-1, их диагностики и лечения. Несколько настораживает отсутствие серьезных популяционных исследований по распространенности этого вируса – фактически, диагностика на HTLV-1 предусмотрена только у доноров и у беременных. До сих пор этот вирус считается эндемичным для ряда территорий (Африка, Австралия, Ближний Восток, Япония и др.) и некоторых коренных народов, но, учитывая беспрецедентные миграционные потоки и международные связи в современном мире, мы считаем важным привлечь к нему внимание как эпидемиологов, так и клиницистов. INTRODUCTION: Human T-lymphotropic virus type 1 (HTLV-1) belongs to the Retroviridae family (genus Deltaretrovirus) and is directly involved in carcinogenesis. The HTLV-1 genome is represented by plus-strand RNA, which is transcribed into proviral DNA and then integrated into the genome of the host cell. After integration, HTLV-1 is present in the cells in the form of a provirus. As in the case of the human immunodeficiency virus, the main targets of HTLV-1 are CD4 + T lymphocytes. The virus is transmitted sexually, through blood transfusion, and breastfeeding by biological fluids - sperm, blood, and breast milk. The epidemiology of HTLV-1 remains a mystery: clusters of high endemicity are often located near areas where the virus is virtually absent. AIM: To analyze and discuss the clinical picture, diagnostics, and treatment of diseases caused by HTLV-1. METHODS: A literature search was conducted in the databases PubMed, eLIBRARY.ru, and cyberleninka.ru using the keywords: “HTLV-1” + “diseases”, “HTLV-1” + “diagnosis”, “HTLV-1” + “epidemiology”, “HTLV-1” + “treatment”, “HTLV-1” + “Russia” in English and Russian languages. The primary search was conducted for papers published in 2020–2024. RESULTS: HTLV-1 infection is associated with diseases such as T-cell leukemia/lymphoma and myelopathy/tropical spastic paraparesis. HTLV-1 infection causes pathologies in most organs of the human body. Since diseases associated with HTLV-1 are most often asymptomatic, etiological diagnoses are performed at the stage of pathological development or when screening donor blood for pathogens. CONCLUSION: In this review, we analyze and discuss the clinical manifestations and course of diseases caused by HTLV-1, their diagnosis and treatment. The lack of reliable population-based studies on the prevalence of this virus is alarming. In fact, the diagnosis of HTLV-1 is provided only for blood donors and pregnant women. Currently, this virus is considered endemic to several territories (Africa, Australia, the Middle East, Japan, etc.) and some indigenous peoples. However, we consider it important to draw the attention of both epidemiologists and clinicians to HTLV-1, given the unprecedented migration flows and international connections in the modern world.
- 1 January 2024
- Published by Doctrine in Microbiology Independent Research Journal (MIR Journal)
- Vol. 11 (1) , 57-69
Open AccessЗаболевания, ассоциированные с Т-лимфотропным вирусом типа 1 человека (HTLV-1)
ВВЕДЕНИЕ: Т-лимфотропный вирус типа 1 человека (HTLV-1) относится к семейству Retroviridae (род Deltaretrovirus) и напрямую участвует в канцерогенезе. Геном HTLV-1 представлен плюс-цепью РНК, которая транскрибируется в провирусную ДНК, а затем встраивается в геном клетки хозяина. После интеграции HTLV-1 присутствует в клетке в форме провируса. Как и для вируса иммунодефицита человека, основными мишенями HTLV-1 служат CD4 + T-лифоциты. Вирус передается через биологические жидкости организма: сперму, кровь и грудное молоко, – то есть половым путем, при гемотрансфузии и грудном вскармливании. Что касается эпидемиологии HTLV-1, то она до сих пор остается загадкой: кластеры с высокой эндемичностью часто расположены вблизи районов, где вирус практически отсутствует. ЦЕЛЬ: Проанализировать клиническую картину, диагностику и лечение заболеваний, вызванных HTLV-1. МЕТОДЫ: Проведен поиск литературы в базах PubMed, elibrary.ru и cyberleninka.ru по ключевым словам: «HTLV-1»+«diseases», «HTLV-1»+«diagnosis», «HTLV-1»+«epidemiology», «HTLV-1»+«treatment», «HTLV-1»+«Russia»; «HTLV-1»+«болезни», «HTLV-1»+«диагностика», «HTLV-1»+«эпидемиология», «HTLV-1»+«лечение», «HTLV-1»+«Россия». Основной поиск проведен за 2020–2024 гг. РЕЗУЛЬТАТЫ: С HTLV-1 связаны такие заболевания, как Т-клеточный лейкоз/лимфома и миелопатия/тропический спастический парапарез. При HTLV-1-инфекции регистрируют патологии большинства систем органов. В связи с тем, что ассоциированные с HTLV-1 заболевания чаще всего протекают бессимптомно, этиологическую диагностику проводят уже на стадии развития патологии или при скрининге крови доноров на патогены. ЗАКЛЮЧЕНИЕ: В обзоре рассмотрены вопросы клинических проявлений и течения заболеваний, вызванных HTLV-1, их диагностики и лечения. Несколько настораживает отсутствие серьезных популяционных исследований по распространенности этого вируса – фактически, диагностика на HTLV-1 предусмотрена только у доноров и у беременных. До сих пор этот вирус считается эндемичным для ряда территорий (Африка, Австралия, Ближний Восток, Япония и др.) и некоторых коренных народов, но, учитывая беспрецедентные миграционные потоки и международные связи в современном мире, мы считаем важным привлечь к нему внимание как эпидемиологов, так и клиницистов. INTRODUCTION: Human T-lymphotropic virus type 1 (HTLV-1) belongs to the Retroviridae family (genus Deltaretrovirus) and is directly involved in carcinogenesis. The HTLV-1 genome is represented by plus-strand RNA, which is transcribed into proviral DNA and then integrated into the genome of the host cell. After integration, HTLV-1 is present in the cells in the form of a provirus. As in the case of the human immunodeficiency virus, the main targets of HTLV-1 are CD4 + T lymphocytes. The virus is transmitted sexually, through blood transfusion, and breastfeeding by biological fluids - sperm, blood, and breast milk. The epidemiology of HTLV-1 remains a mystery: clusters of high endemicity are often located near areas where the virus is virtually absent. AIM: To analyze and discuss the clinical picture, diagnostics, and treatment of diseases caused by HTLV-1. METHODS: A literature search was conducted in the databases PubMed, eLIBRARY.ru, and cyberleninka.ru using the keywords: “HTLV-1” + “diseases”, “HTLV-1” + “diagnosis”, “HTLV-1” + “epidemiology”, “HTLV-1” + “treatment”, “HTLV-1” + “Russia” in English and Russian languages. The primary search was conducted for papers published in 2020–2024. RESULTS: HTLV-1 infection is associated with diseases such as T-cell leukemia/lymphoma and myelopathy/tropical spastic paraparesis. HTLV-1 infection causes pathologies in most organs of the human body. Since diseases associated with HTLV-1 are most often asymptomatic, etiological diagnoses are performed at the stage of pathological development or when screening donor blood for pathogens. CONCLUSION: In this review, we analyze and discuss the clinical manifestations and course of diseases caused by HTLV-1, their diagnosis and treatment. The lack of reliable population-based studies on the prevalence of this virus is alarming. In fact, the diagnosis of HTLV-1 is provided only for blood donors and pregnant women. Currently, this virus is considered endemic to several territories (Africa, Australia, the Middle East, Japan, etc.) and some indigenous peoples. However, we consider it important to draw the attention of both epidemiologists and clinicians to HTLV-1, given the unprecedented migration flows and international connections in the modern world.
- Open Access
- 1 January 2023
- Published by Doctrine in Microbiology Independent Research Journal (MIR Journal)
- Vol. 10 (1) , 70-90
Biological markers of sepsis
Currently, the issues of early sepsis diagnosis, assessment of the effectiveness of therapies conducted, and disease prognosis are extremely relevant. In the case of sepsis, timely medical assistance is complicated by the ambiguity of symptoms and the absence of a specific diagnostic test. Therefore, the search for sepsis biomarkers with diagnostic, prognostic, and therapeutic potential is underway in medical centers worldwide. This review summarizes research results regarding the diagnostic values of sepsis biomarkers – their sensitivity, specificity, and prognostic value – as presented in scientific publications indexed in international databases.
- 1 January 2023
- Published by Doctrine in Microbiology Independent Research Journal (MIR Journal)
- Vol. 10 (1) , 70-90
Open AccessBiological markers of sepsis
Currently, the issues of early sepsis diagnosis, assessment of the effectiveness of therapies conducted, and disease prognosis are extremely relevant. In the case of sepsis, timely medical assistance is complicated by the ambiguity of symptoms and the absence of a specific diagnostic test. Therefore, the search for sepsis biomarkers with diagnostic, prognostic, and therapeutic potential is underway in medical centers worldwide. This review summarizes research results regarding the diagnostic values of sepsis biomarkers – their sensitivity, specificity, and prognostic value – as presented in scientific publications indexed in international databases.
- Open Access
- 1 January 2023
- Published by Doctrine in Microbiology Independent Research Journal (MIR Journal)
- Vol. 10 (1) , 70-90
Биологические маркеры сепсиса
В настоящее время проблема ранней диагностики сепсиса, оценки эффективности проводимой терапии и прогноза течения заболевания крайне актуальна. При сепсисе своевременное оказание медицинской помощи осложнено нечеткостью симптомов и отсутствием специфического диагностического теста. В связи с этим во всем мире ведется поиск биологических маркеров сепсиса: диагностических, прогностических и терапевтических. В обзоре суммированы результаты исследований по диагностической ценности биологических маркеров сепсиса, их чувствительности, специфичности и прогностической ценности из научных публикаций, представленных в международных базах данных.
- 1 January 2023
- Published by Doctrine in Microbiology Independent Research Journal (MIR Journal)
- Vol. 10 (1) , 70-90
Open AccessБиологические маркеры сепсиса
В настоящее время проблема ранней диагностики сепсиса, оценки эффективности проводимой терапии и прогноза течения заболевания крайне актуальна. При сепсисе своевременное оказание медицинской помощи осложнено нечеткостью симптомов и отсутствием специфического диагностического теста. В связи с этим во всем мире ведется поиск биологических маркеров сепсиса: диагностических, прогностических и терапевтических. В обзоре суммированы результаты исследований по диагностической ценности биологических маркеров сепсиса, их чувствительности, специфичности и прогностической ценности из научных публикаций, представленных в международных базах данных.
- Open Access
- 1 January 2023
- Published by Doctrine in Microbiology Independent Research Journal (MIR Journal)
- Vol. 10 (1) , 20-38
Factors affecting the severity of COVID-19 and the development of complications
Due to the prevalence and diversity of both symptoms and outcomes of COVID-19, understanding the factors that determine the risk of the severe course of this disease and its possible complications is of particular importance. In this review, we present the information on the specifics of COVID-19 pathogenesis and give a theoretical justification for the factors that determine the course of this disease in patients of different age groups, patients with chronic pathology, and pregnant women. Particular attention is paid to the post-COVID syndrome.
- 1 January 2023
- Published by Doctrine in Microbiology Independent Research Journal (MIR Journal)
- Vol. 10 (1) , 20-38
Open AccessFactors affecting the severity of COVID-19 and the development of complications
Due to the prevalence and diversity of both symptoms and outcomes of COVID-19, understanding the factors that determine the risk of the severe course of this disease and its possible complications is of particular importance. In this review, we present the information on the specifics of COVID-19 pathogenesis and give a theoretical justification for the factors that determine the course of this disease in patients of different age groups, patients with chronic pathology, and pregnant women. Particular attention is paid to the post-COVID syndrome.
- Open Access
- 1 January 2023
- Published by Doctrine in Microbiology Independent Research Journal (MIR Journal)
- Vol. 10 (1) , 20-38
Факторы, влияющие на тяжесть течения COVID-19 и развитие осложнений
В связи с широким распространением и «многоликостью» как симптоматики, так и исходов COVID-19 особую актуальность приобретает понимание факторов, определяющих риск тяжелого течения заболевания и возможных осложнений. В обзоре представлена информация об особенностях патогенеза COVID-19, дали теоретическое обоснование факторов, обусловливающих особенности заболевания у пациентов разных возрастных групп, беременных, а также при хронических патологиях. Отдельное внимание уделено постковидному синдрому.
- 1 January 2023
- Published by Doctrine in Microbiology Independent Research Journal (MIR Journal)
- Vol. 10 (1) , 20-38
Open AccessФакторы, влияющие на тяжесть течения COVID-19 и развитие осложнений
В связи с широким распространением и «многоликостью» как симптоматики, так и исходов COVID-19 особую актуальность приобретает понимание факторов, определяющих риск тяжелого течения заболевания и возможных осложнений. В обзоре представлена информация об особенностях патогенеза COVID-19, дали теоретическое обоснование факторов, обусловливающих особенности заболевания у пациентов разных возрастных групп, беременных, а также при хронических патологиях. Отдельное внимание уделено постковидному синдрому.
- Open Access
- 1 January 2021
- Published by Doctrine in Microbiology Independent Research Journal (MIR Journal)
- Vol. 8 (1) , 50-61
Mutations in the genome of avian influenza viruses of the H1 and H5 subtypes responsible for adaptation to mammals
Avian influenza viruses of the H1 and H5 subtypes were involved in the formation of highly pathogenic viruses that caused pandemics and panzootics in the 20th–21st centuries. In order to assess the zoonotic potential of viruses of these subtypes, two viruses of the H1N1 and H5N3 subtypes have been isolated from wild ducks in Moscow and adapted for growth in mouse lungs. Their phenotypic properties were studied, and the genetic changes that occurred during adaptation were identified. The original A/duck/Moscow/4970/2013 (H1N1) and A/duck/Moscow/4182-C/2010 (H5N3) viruses were apathogenic for mice but became pathogenic after 7–10 passages in mouse lungs. Complete genome sequencing revealed 2 amino acid substitutions in the proteins of the H1N1 mouse-adapted variant (Glu627Lys in PB2 and Asp35Asn in hemagglutinin (HA) – numbering according to H3) and 6 mutations in the proteins of H5N3 virus (Glu627lys in PB2, Val113Ala in PB1, Ser82Pro in PB1-F2, Lys52Arg in HA2, Arg65Lys in NP, and Ser-59Ile in NA). The increase in virulence is most likely due to a Glu627Lys substitution in the protein PB2 found in both viruses. The replacement Asp35Asn in HA of the mouse-adapted H1N1 virus is associated with an increase in the pH value of the HA transition to 5.5 versus 5.0 for that of the wild virus. The mutations found in the HA, NA, and PB1-F2 proteins of the adapted H5N3 variant are unique. The mutations Glu627Lys in PB2, Arg65Lys in NP, and Val113Ala in PB1 are most likely host adaptive.
- 1 January 2021
- Published by Doctrine in Microbiology Independent Research Journal (MIR Journal)
- Vol. 8 (1) , 50-61
Open AccessMutations in the genome of avian influenza viruses of the H1 and H5 subtypes responsible for adaptation to mammals
Avian influenza viruses of the H1 and H5 subtypes were involved in the formation of highly pathogenic viruses that caused pandemics and panzootics in the 20th–21st centuries. In order to assess the zoonotic potential of viruses of these subtypes, two viruses of the H1N1 and H5N3 subtypes have been isolated from wild ducks in Moscow and adapted for growth in mouse lungs. Their phenotypic properties were studied, and the genetic changes that occurred during adaptation were identified. The original A/duck/Moscow/4970/2013 (H1N1) and A/duck/Moscow/4182-C/2010 (H5N3) viruses were apathogenic for mice but became pathogenic after 7–10 passages in mouse lungs. Complete genome sequencing revealed 2 amino acid substitutions in the proteins of the H1N1 mouse-adapted variant (Glu627Lys in PB2 and Asp35Asn in hemagglutinin (HA) – numbering according to H3) and 6 mutations in the proteins of H5N3 virus (Glu627lys in PB2, Val113Ala in PB1, Ser82Pro in PB1-F2, Lys52Arg in HA2, Arg65Lys in NP, and Ser-59Ile in NA). The increase in virulence is most likely due to a Glu627Lys substitution in the protein PB2 found in both viruses. The replacement Asp35Asn in HA of the mouse-adapted H1N1 virus is associated with an increase in the pH value of the HA transition to 5.5 versus 5.0 for that of the wild virus. The mutations found in the HA, NA, and PB1-F2 proteins of the adapted H5N3 variant are unique. The mutations Glu627Lys in PB2, Arg65Lys in NP, and Val113Ala in PB1 are most likely host adaptive.
- Open Access
- 1 January 2021
- Published by Doctrine in Microbiology Independent Research Journal (MIR Journal)
- Vol. 8 (1) , 50-61
Мутации в геноме вирусов гриппа птиц подтипов Н1 и Н5, ответственные за адаптацию к млекопитающим
Вирусы гриппа птиц подтипов Н1 и Н5 участвовали в формировании высокопатогенных вариантов вирусов, вызвавших пандемии и панзоотии в XX–XXI веках. С целью оценки зоонозного потенциала вирусов этих подтипов, выделенных от диких уток в черте Москвы, была проведена адаптация вирусов к размножению в легких мышей, изучены их фенотипические свойства и идентифицированы генетические изменения, возникшие при адаптации. Изначально апатогенные для мышей вирусы A/duck/Moscow/4970/2013 (H1N1) и A/duck/Moscow/4182 C/2010 (H5N3) после 7–10 пассажей через легкие мышей изменили фенотип на патогенный. Полногеномное секвенирование выявило в адаптированных к мышам вирусах 2 аминокислотные замены в вирусе гриппа H1N1 (Glu627Lys в белке PB2 и Asp35Asn в гемагглютинине (HA) — нумерация по H3) и 6 мутаций в белках вируса H5N3 (Glu627Lys в PB2, Val113Ala в PB1, Ser82Pro в PB1 F2, Lys52Arg в HA2, Arg65Lys в NP и Ser59Ile в NA). Возрастание вирулентности для мышей, скорее всего, обусловлено общей для обоих вирусов заменой – Glu627Lys в белке PB2. Замена Asp35Asn в HA адаптированного к мышам вируса гриппа H1N1 ассоциирована с возрастанием значения рН конформационного перехода HA с 5.0 до 5.5 относительно HA дикого вируса. Обнаруженные в адаптированном варианте H5N3 мутации в белках НА, NA и PB1 F2 — уникальные. Мутации Glu627Lys в PB2, Arg65Lys в NP и Val113Ala в PB1, скорее всего, носят адаптационный характер.
- 1 January 2021
- Published by Doctrine in Microbiology Independent Research Journal (MIR Journal)
- Vol. 8 (1) , 50-61
Open AccessМутации в геноме вирусов гриппа птиц подтипов Н1 и Н5, ответственные за адаптацию к млекопитающим
Вирусы гриппа птиц подтипов Н1 и Н5 участвовали в формировании высокопатогенных вариантов вирусов, вызвавших пандемии и панзоотии в XX–XXI веках. С целью оценки зоонозного потенциала вирусов этих подтипов, выделенных от диких уток в черте Москвы, была проведена адаптация вирусов к размножению в легких мышей, изучены их фенотипические свойства и идентифицированы генетические изменения, возникшие при адаптации. Изначально апатогенные для мышей вирусы A/duck/Moscow/4970/2013 (H1N1) и A/duck/Moscow/4182 C/2010 (H5N3) после 7–10 пассажей через легкие мышей изменили фенотип на патогенный. Полногеномное секвенирование выявило в адаптированных к мышам вирусах 2 аминокислотные замены в вирусе гриппа H1N1 (Glu627Lys в белке PB2 и Asp35Asn в гемагглютинине (HA) — нумерация по H3) и 6 мутаций в белках вируса H5N3 (Glu627Lys в PB2, Val113Ala в PB1, Ser82Pro в PB1 F2, Lys52Arg в HA2, Arg65Lys в NP и Ser59Ile в NA). Возрастание вирулентности для мышей, скорее всего, обусловлено общей для обоих вирусов заменой – Glu627Lys в белке PB2. Замена Asp35Asn в HA адаптированного к мышам вируса гриппа H1N1 ассоциирована с возрастанием значения рН конформационного перехода HA с 5.0 до 5.5 относительно HA дикого вируса. Обнаруженные в адаптированном варианте H5N3 мутации в белках НА, NA и PB1 F2 — уникальные. Мутации Glu627Lys в PB2, Arg65Lys в NP и Val113Ala в PB1, скорее всего, носят адаптационный характер.
- 30 June 2004
- Published by Springer Nature in Archives of Virology
- Vol. 149 (11) , 2131-2140
Specificity of neuraminidase activity from influenza viruses isolated in different hosts tested with novel substrates
Influenza A and B viruses isolated in Vero and Madin Darby canine kidney (MDCK) cells as well as in fertilised hen eggs were tested for the specificity of their neuraminidase (NA) activity. Novel glycoconjugates with variations of terminally bound sialic acid mimicking the three main receptor types for influenza viruses were synthesised. These new substrates together with the lectin from Ricinus communis were used in a solid phase microtitre assay for the detection of NA specificity. Egg or MDCK isolated virus strains tended to exhibit highest NA activity against 3′sialyl-bound sialic acid whereas Vero isolated strains favoured 6′sialyl-(N-acetyllactosamine)-bound sialic acid. Differences were more pronounced for influenza A than for influenza B strains.
- 30 June 2004
- Published by Springer Nature in Archives of Virology
- Vol. 149 (11) , 2131-2140
Specificity of neuraminidase activity from influenza viruses isolated in different hosts tested with novel substrates
Influenza A and B viruses isolated in Vero and Madin Darby canine kidney (MDCK) cells as well as in fertilised hen eggs were tested for the specificity of their neuraminidase (NA) activity. Novel glycoconjugates with variations of terminally bound sialic acid mimicking the three main receptor types for influenza viruses were synthesised. These new substrates together with the lectin from Ricinus communis were used in a solid phase microtitre assay for the detection of NA specificity. Egg or MDCK isolated virus strains tended to exhibit highest NA activity against 3′sialyl-bound sialic acid whereas Vero isolated strains favoured 6′sialyl-(N-acetyllactosamine)-bound sialic acid. Differences were more pronounced for influenza A than for influenza B strains.